BioSpace News Archive

DEFINING CLEAR DEVELOPMENT PATHWAY FOR NEXT GENERATION OF PSYCHEDELIC MEDICINES TO TREAT ADDICTION

Ms. Johns has more than 30 years of experience in the pharmaceutical industry, playing a key role in product development and regulatory strategy in support of numerous marketing applications across a variety of therapeutic fields.

Skinopathy Inc., a Canadian medical technology company, will soon release a revolutionary skin disease mobile app that will change how we practice medicine.

The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards. The awards, issued near the start of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.

Process Systems Enterprise (PSE), A Siemens Business, today announced the full release of gPROMS FormulatedProducts 2.0, the mechanistic model-based environment for integrated digital design of robust formulated products and their manufacturing processes, and related digital process operation.

Onco360 ® , the nation’s largest independent Oncology Pharmacy, has been selected by ADC Therapeutics to be the exclusive specialty pharmacy partner for ZYNLONTA™ (loncastuximab tesirine-lpyl), a new intravenous therapy option for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL)

Project Lyme, a 5013 focused on eradicating the epidemic of tick-borne diseases, is pleased to announce that on May 1st, 2021, the Helmsley Building, a 35-story structure at 230 Park Avenue between East 45th and 46th streets in Midtown Manhattan will light green in honor of World Lyme Day.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

CORRECTING and REPLACING Kermode Biotechnologies Announced that it is Actively Engaged in Discovery to Identify the Mode of Transmission for the African Swine Fever Virus (ASFV) While there is currently no regulatory-approved vaccine or therapeutic antibody to combat the risks posed by ASFV to global pig livestock and food security, Kermode has been working to solve these challenges since the 2018 outbreak.

Verily, an Alphabet company, announced the appointment of Lisa Greenbaum to the newly-created role of chief revenue officer.